File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Neuromodulation in Psychiatric Disorders

TitleNeuromodulation in Psychiatric Disorders
Authors
KeywordsPsychiatry
Obsessive-compulsive disorder
Neuromodulation
Deep brain stimulation
Tourette syndrome
Depression
Transcranial stimulation
Addiction
Alzheimer's disease
Vagus nerve stimulation
Issue Date2012
Citation
International Review of Neurobiology, 2012, v. 107, p. 283-314 How to Cite?
AbstractPsychiatric disorders are worldwide a common cause of severe and long-term disability and socioeconomic burden. The management of patients with psychiatric disorders consists of drug therapy and/or psychotherapy. However, in some patients, these treatment modalities do not produce sufficient therapeutic effects or induce intolerable side effects. For these patients, neuromodulation has been suggested as a potential treatment modality. Neuromodulation includes deep brain stimulation, vagal nerve stimulation, and transcranial magnetic and electrical stimulation. The rationale for neuromodulation is derived from the research identifying neurobiologically localized substrates for refractory psychiatric symptoms. Here, we review the clinical data on neuromodulation in the major psychiatric disorders. Relevant data from animal models will also be discussed to explain the neurobiological basis of the therapy. © 2012 Elsevier Inc.
Persistent Identifierhttp://hdl.handle.net/10722/219879
ISSN
2015 Impact Factor: 2.699
2015 SCImago Journal Rankings: 1.324

 

DC FieldValueLanguage
dc.contributor.authorTemel, Yasin-
dc.contributor.authorHescham, Sarah A.-
dc.contributor.authorJahanshahi, Ali-
dc.contributor.authorJanssen, Marcus L F-
dc.contributor.authorTan, Sonny K H-
dc.contributor.authorvan Overbeeke, Jacobus J.-
dc.contributor.authorAckermans, Linda-
dc.contributor.authorOosterloo, Mayke-
dc.contributor.authorDuits, Annelien-
dc.contributor.authorLeentjens, Albert F G-
dc.contributor.authorLim, LeeWei-
dc.date.accessioned2015-09-24T04:44:14Z-
dc.date.available2015-09-24T04:44:14Z-
dc.date.issued2012-
dc.identifier.citationInternational Review of Neurobiology, 2012, v. 107, p. 283-314-
dc.identifier.issn0074-7742-
dc.identifier.urihttp://hdl.handle.net/10722/219879-
dc.description.abstractPsychiatric disorders are worldwide a common cause of severe and long-term disability and socioeconomic burden. The management of patients with psychiatric disorders consists of drug therapy and/or psychotherapy. However, in some patients, these treatment modalities do not produce sufficient therapeutic effects or induce intolerable side effects. For these patients, neuromodulation has been suggested as a potential treatment modality. Neuromodulation includes deep brain stimulation, vagal nerve stimulation, and transcranial magnetic and electrical stimulation. The rationale for neuromodulation is derived from the research identifying neurobiologically localized substrates for refractory psychiatric symptoms. Here, we review the clinical data on neuromodulation in the major psychiatric disorders. Relevant data from animal models will also be discussed to explain the neurobiological basis of the therapy. © 2012 Elsevier Inc.-
dc.languageeng-
dc.relation.ispartofInternational Review of Neurobiology-
dc.subjectPsychiatry-
dc.subjectObsessive-compulsive disorder-
dc.subjectNeuromodulation-
dc.subjectDeep brain stimulation-
dc.subjectTourette syndrome-
dc.subjectDepression-
dc.subjectTranscranial stimulation-
dc.subjectAddiction-
dc.subjectAlzheimer's disease-
dc.subjectVagus nerve stimulation-
dc.titleNeuromodulation in Psychiatric Disorders-
dc.typeArticle-
dc.description.natureLink_to_subscribed_fulltext-
dc.identifier.doi10.1016/B978-0-12-404706-8.00015-2-
dc.identifier.pmid23206687-
dc.identifier.scopuseid_2-s2.0-84872375107-
dc.identifier.volume107-
dc.identifier.spage283-
dc.identifier.epage314-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats